logo

Rosetta Genomics Ltd. (ROSG)



Trade ROSG now with
  Date
  Headline
8/4/2017 7:15:07 AM Rosetta Genomics Trading Expected To Resume At 7:30 AM ET
8/4/2017 7:02:00 AM Rosetta Genomics Trading Halted; Pending News
3/20/2017 8:08:55 AM Rosetta Genomics USPTO Granted Patent Allowance For Patent Application No. 15/237,364
3/16/2017 12:12:18 PM Rosetta Genomics Announces 1-for-12 Reverse Stock Split
2/6/2017 8:07:23 AM Rosetta Genomics Says USPTO Granted Patent Allowances For Two RosettaGx Reveal MicroRNAs
11/21/2016 8:10:32 AM Rosetta Genomics Enters Research Collaboration Using MicroRNA Biomarkers
10/20/2016 8:42:22 AM Rosetta Genomics Appoints Mark Willig As Chief Commercial Officer
9/26/2016 4:08:55 PM Rosetta Genomics Q2 EPS $0.16 Vs. $0.20 Year Ago
7/11/2016 9:06:38 AM Rosetta Genomics Gets U.S. Patent Allowance For MicroRNA-based Ovarian Cancer Treatment
6/21/2016 9:13:17 AM Rosetta Genomics Gets Approval From New York State For HEME FISH-based Assays
5/19/2016 8:05:39 AM Rosetta Genomics Q1 Net Loss $4.0 Mln Or $0.20 Per Ordinary Share
2/29/2016 9:17:40 AM Rosetta Genomics Appoints Ana Ward As EVP, Legal And Corporate Development
2/1/2016 8:11:56 AM Rosetta Genomics Enters Agreement With America’s Choice Provider Network For Diagnostic Tests And Services
1/11/2016 9:12:36 AM Rosetta Genomics Receives U.S. Patent Allowance For Use Of MicroRNA Molecules For Liver Cancer Treatment
12/14/2015 8:19:11 AM Rosetta Genomics And Biocept Advance Collaboration To Studies Aimed At MicroRNA Profiling Of Circulating Tumor Cells
12/1/2015 8:19:50 AM Rosetta Genomics Q3 Net Loss $3.9 Mln Or $0.27 Per Share
11/4/2015 8:34:01 AM Rosetta Genomics Appoints Maria Fe Paz Interim Chief Medical Officer
11/4/2015 8:32:50 AM Rosetta Genomics Appoints Maria Fe Paz Chief Medical Officer
  
 
>